FDA Inspection 1027721 — SGS North America Inc.

SGS North America Inc. — FEI 2214690

The FDA completed an inspection of SGS North America Inc. on August 30, 2017 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 30, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)